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11. Foreword: Purpose of the manual
Law enforcement authorities and other clients of drug analysis laboratories, for 
example, police, customs, prosecutors and defence solicitors, need results that are:
reliable; "
valid; "
based on standard procedures; "
compatible with results in other laboratories; "
compliant with the evidentiary standards of the respective judicial,  "
administrative and legal systems;
obtained in an effective and efficient manner in the required timescale; "
value for money.  "
The quality of the analyses and results of such laboratories have significant implica-
tions for the justice system, law enforcement, crime prevention and health policy, as 
well as for the international harmonization and worldwide exchange and coordination 
of drug information and data. [1]
The compatibility and acceptance of laboratory results between countries is facili-
tated by their compliance with EN ISO/IEC 17025:2005 (ISO 17025) [2], the inter-
national quality standard for testing and calibration laboratories, and the associated 
ILAC recommendations G19:2002 for forensic science laboratories [3]. Compliance 
with ISO 17025 also ensures conformity with the requirements of ISO 9001 that 
are relevant to drug testing laboratories. However, compliance with ISO 9001 alone is 
not a substitute for compliance with ISO 17025, as it does not address the technical 
competence of the testing laboratory.
The guidelines that follow are specifically for drug testing laboratories and are based 
on the general principles of the ISO 17025 standard. They also take account of the 
UNODC Recommended Guidelines for Quality Assurance and Good Laboratory 
Practice [4], SWGDRUG Recommendations [5], the requirements of the American 
Society of Crime Laboratory Directors’ Laboratory Accreditation Manual [6], SOFT/
AAFS Forensic Toxicology Laboratory Guidelines [7] and European Laboratory 
Guidelines for Legally Defensible Workplace Drug Testing. [8, 9] 
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Dedication to quality is the fundamental principle of a forensic laboratory. The aim 
of this document is to provide guidance to deliver high quality in a forensic labora-
tory, use the appropriate techniques to find the “answers” and to improve it  constantly. 
It is a “how to do document” and includes some areas that are not explicitly covered 
in depth by ISO 17025. 
It is intended to serve as an introduction to laboratory quality management systems 
and to provide practical guidance to national authorities and analysts for the imple-
mentation of such systems based on best practice in the laboratory. “Best practice” 
may vary between laboratories because the resources at their disposal and the legal 
requirements are different. For example, on an international scale, the state-of-the-art 
in instrumentation may stipulate LC-MS-MS as the basis for best practice, but this 
equipment is unavailable in many laboratories which nevertheless produce good 
results. Also, in some jurisdictions it may be necessary to quantify drugs or identify 
specific isomers while it may not be required in other countries. “Best practice” 
should therefore be interpreted as the best achievable practice within the laboratory 
and jurisdiction concerned, as long as the work carried out meets the requirements 
in this document. There are different ways of achieving the end result and these 
guidelines will assist laboratory managers to ensure that their way is at an interna-
tionally acceptable level.
Compliance of all drug testing laboratories with the guidelines that follow is essential 
to ensure the harmonized performance of drug testing laboratories worldwide. These 
guidelines can also be used as a basic guide not only for laboratories but also for 
auditors and inspectors in the evaluation of drug testing laboratories during the 
accreditation process. 
External accreditation to ISO 17025 is the process by which an authorized accredita-
tion body formally recognizes that a laboratory is competent to carry out specific 
tasks. In the accreditation process, the laboratory demonstrates that its management, 
operations, personnel, procedures, equipment, accommodation, security, and health 
and safety procedures meet established quality standards. While it may require a 
significant investment of resources, it would provide laboratory management, law 
enforcement authorities and other clients with added confidence in the performance 
of the laboratory. External accreditation is therefore an appropriate goal in the 
 development of a quality management system and many drug testing laboratories 
in several countries have now been accredited.
In future, it is possible that only accredited drug testing laboratories will be 
 authorized to function as forensic toxicology laboratories or as police crime 
laboratories. 
UNODC provides support to laboratories in introducing and implementing a quality 
management system through a number of initiatives, including the provision of 
 reference samples of controlled substances, laboratory manuals on recommended 
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methods, training opportunities and the International Collaborative Exercises scheme, 
and by promoting and facilitating the exchange of information, material and 
data. [10]
Throughout the manual, examples are given to clarify various points made. 
These are preceded by the phrase “for example”. Where this occurs, the 
examples given are not exhaustive but merely intended to illustrate the 
respective points.
42. Introduction
Laboratories following the practical guidelines described in this document should 
meet the requirements of ISO 17025. The guidelines are based on theoretical con-
siderations as well as practical experience gained in the laboratory accreditation 
process. They are designed to ensure the correct identification of substances, to 
ensure that the processes undertaken will stand up to legal scrutiny and to provide 
safeguards to protect the rights of individuals. The aim of the guidelines is to 
improve the quality of laboratory services and to define common quality assurance 
criteria.
Attention is drawn to both technical requirements (including the importance of 
trained staff, appropriate accommodation and environmental conditions, method 
 validation, access to required equipment and reference standards, quality control and 
the reporting of results) and management requirements (including document control, 
responsiveness to the needs of the client, preventive and corrective actions, the need 
for regular audits of compliance with the quality management system and continuous 
improvement). 
The guidelines consider all key stages of the drug testing process from collection 
of samples and analysis to the interpretation and reporting of results. Laboratories 
that carry out all stages of the process should ensure that the guidelines in this 
document are met in their entirety. In those instances where clients undertake one 
or more stages of the process within their own organizations, (for example, sample 
collection or interpretation/review), it is the duty of the laboratory to ensure that 
the client understands the full implications of this in the drug testing process.
53. Quality Management System
The laboratory must have a Quality Management System (QMS) which covers its 
activities, including drugs sampling, analysis and reporting, whether these are within 
the main laboratory facility itself, mobile/temporary facilities, or external locations 
such as a clandestine laboratory, the roadside or the locus of a large drug seizure. 
The QMS consists of documentation of the laboratory’s policies, systems, procedures 
and instructions to the extent necessary to assure the quality of its results, to meet 
relevant jurisdictional, regulatory and safety requirements and to satisfy the needs 
of the clients.
The hierarchy of the QMS is presented in figure 1. 
Figure 1. Hierarchy of the Quality Management System
Code of ethics
Standard ISO/IEC 
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Client  
requirements
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3.1. Quality policy [11] 
The laboratory should have a concise statement from top management declaring its 
commitment to achieve quality in all aspects of the work of the laboratory. It should 
also set forth any codes of practice or ethics that apply. This statement constitutes 
the quality policy of the laboratory. [4]
The whole personnel, from the highest placed director to the assisting staff, are 
responsible for adherence to this quality policy.
The policy statement should include at least the following points:
The management’s declaration of its commitment to quality and continuous  "
improvement in the performance of the laboratory;
A management statement that the quality of the work of the laboratory will  "
be fit for purpose, in that it will withstand scientific and legal scrutiny as well 
as meeting the budgetary and timeliness requirements agreed with the client; 
A management statement that it is committed to providing the resources  "
necessary to manage and operate the quality system;
A declaration that all staff have a role in ensuring that the laboratory’s work  "
is carried out according to the requirements of ISO 17025 and other codes 
of practice applicable to the type of work, as well as relevant jurisdictional, 
regulatory and safety requirements as specified in the laboratory’s QMS; 
Personnel responsible for the QMS should have direct access to the highest level 
of management concerning laboratory policy.
3.2. Quality manual
The laboratory should have a manual describing the QMS. The quality manual 
should outline the organization and format of documents used in the QMS as well 
as the roles and responsibilities of the personnel responsible for management of the 
QMS and for management of the technical procedures. The quality manual should 
also document the administrative, organizational and scientific aspects of the work 
of the laboratory necessary for its proper management.
The documentation should be readily available in the laboratory and accessible to 
all relevant staff. It should be continuously reappraised and updated to ensure that 
changing circumstances are taken into account. 
The use of documented procedures ensures that the work being performed is under 
control and achieves its intended purpose, that the requirements of international quality 
standards are fulfilled and that the results of analyses of seized materials or biological 
samples can be used with confidence in any subsequent legal proceedings. 
74. Management requirements
4.1. Laboratory organization
The quality manual should define the following: 
The organization and management structure of the laboratory and its place  "
in any larger organization, together with the relationships which exist 
between quality management, technical operations and support services. In 
addition, if the laboratory is part of a larger organization, the responsibili-
ties of any person in that organization who is involved in, or can influence, 
the work of the laboratory should be defined; 
Who is legally responsible for the work of the laboratory in the event of  "
legal action being taken (for example, by a client). Legal responsibility 
might lie with, for example, the director of an organization which incor-
porates the laboratory, the head of the laboratory or with individual 
scientists;
The responsibility, authority and interrelationships of all personnel who  "
manage, perform or verify work affecting the quality of the results;
Which personnel have managerial and technical authority for quality  "
manage ment, what their specific responsibilities are, nominated deputies 
and what resources are available to them to carry out their duties. These 
should include:
a quality manager who, irrespective of other duties and responsibilities,  –
has defined responsibility and authority for ensuring that the quality 
system is implemented and followed at all times, has direct access to 
the highest level of management at which decisions are made on 
 laboratory policy or resources, maintains and updates the quality  manual, 
monitors laboratory practices, ensures the validation of new technical 
procedures, selects, trains and evaluates internal auditors,  recommends 
training to improve the quality of laboratory staff and proposes improve-
ments in the quality system;
a technical manager or the personnel with responsibility for specified  –
technical operations, the provision of the resources needed to ensure 
the required quality of these operations, the investigation and resolution 
of technical problems and the evaluation of instrument calibration and 
maintenance records.
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The arrangements in place for ensuring that the laboratory’s management  "
and personnel are free from any undue internal and external commercial, 
financial and other pressures and influences that may adversely affect the 
quality of their work, and that they do not become involved in activities 
that would diminish confidence in the laboratory’s competence, impartiality, 
judgement or operational integrity. The reputation of a laboratory is easily 
lost but is difficult to regain;
Safeguards for the protection of clients’ confidential information and pro- "
prietary rights, including procedures for protecting the electronic storage 
and transmission of results.
Arrangements for supervision of staff carrying out laboratory work by  "
 personnel who themselves have demonstrated competence in the work 
undertaken. 
4.2. Document control
A QMS can only operate effectively if the policies, systems, procedures and methods 
are documented and kept up to date. Document control is the mechanism by which 
the QMS documents are created, amended, reviewed, approved, distributed and 
archived to ensure that all staff use the latest authorized versions. 
The quality manager should ensure that all aspects of the laboratory’s work are 
documented in the QMS and that new documents are created by competent person-
nel and authorized by designated staff before being issued. The quality manager 
should also ensure that all documents are subject to periodical review and, where 
necessary, revised to take account of changing circumstances and incorporate best 
practice. Once approved, the quality manager should arrange for documents to be 
made available to all relevant staff in their workplace. When changes have been 
made to existing documents, the quality manager should make sure that the changes 
are highlighted in the latest versions. 
All QMS documents should be uniquely identified and should bear the name/signature 
of the authorizing person. Each page of a document should be individually numbered 
as “page x of y pages” and should include the unique QMS document identifier, date 
of issue and version. This system for page identification minimizes the risk of 
 undetected omission of current pages and undetected retention of obsolete pages. 
If documents are held and distributed electronically, they should be read-only 
 versions which may only be edited by authorized staff. 
A master list bearing the date of issue and, where appropriate, a complete record 
of all versions, the dates on which they were made and the name of the authorizing 
person and distribution list should be maintained. This may be supplemented with 
a sheet attached to each document identifying the same details. 
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The laboratory may allow minor changes to printed documents, such as correction 
of typing errors, to be handwritten on the document in permanent ink, dated and 
authorized. However, a revised version should be issued as soon as practicable. 
Invalid or obsolete documents should be promptly removed from all locations to 
prevent their accidental use. A copy of each obsolete document should be retained 
for either legal or knowledge preservation purposes and suitably marked (for  example, 
“not valid”).
4.3. Review of client requests
The laboratory should have procedures to ensure that the requirements of its clients 
are adequately defined, documented and understood and that it has the capability of 
meeting these requirements before agreeing (making a contract) to do the work. 
This is termed “contract review” in ISO 17025. The agreement may be written or 
oral, but if reached orally it should subsequently be documented. If the laboratory 
does not have the capability, it should attempt to reach agreement with the client 
on what work it could carry out or would subcontract before any work commences. 
Any revised agreement should then be documented. 
The agreement should be kept under review by the client and the laboratory. If new 
requirements are requested by the client, or the laboratory is unable to meet the 
original agreement or the new requirements, this should be communicated between 
the parties, discussed and a revised agreement reached. Records should also be kept 
of all communications between the client and the laboratory related to the work 
being carried out. This will ensure the common understanding of requirements, 
responsibilities and work to be performed by the laboratory, its clients and all other 
parties involved.
4.4. Subcontracting of analytical work
If the laboratory uses another party (subcontractor) to undertake work on its behalf, 
it should have documented policies and processes to ensure that the other party is 
competent to do the work.
4.5. Purchasing services and supplies
The laboratory should have a policy and procedure(s) for the selection and purchase 
of services, reagents and laboratory consumable materials which might affect the 
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quality of its work, for the reception and storage of the reagents and consumables, 
and for ensuring that the services, reagents and consumables comply with the 
 technical specifications described in the QMS before they are purchased and used. 
The laboratory should maintain a record of the actions taken to check compliance 
and the results of those checks.
4.6. Service to client
The laboratory should ensure that it understands its clients’ needs and that they are 
kept up to date on progress with their work. The laboratory should also request 
feedback from its clients on its performance. Both negative and positive feedback 
are important in improving the laboratory’s services. Client confidentiality should 
be respected at all times.
4.7. Complaints
The laboratory should have a system for dealing effectively with client complaints. 
This should include a requirement to inform customers of any actions taken to 
resolve the issue and prevent any recurrence. Records should be maintained of all 
complaints and corrective actions and used as an opportunity to improve quality 
management in the laboratory. Failure to handle complaints from clients to their 
satisfaction can adversely affect the laboratory-client relationship.
4.8. Corrective and preventive actions 
When the work carried out by the laboratory is inconsistent with its QMS (for 
example, the work deviates from an operating procedure, or the requirements of its 
clients), this is termed a “nonconformance” in ISO 17025. The laboratory should 
have systems in place (for example, for checking work within the laboratory, case 
file or QMS audit, staff/customer feedback) to recognize when a nonconformance 
has occurred and how it should be managed. This process should include investi-
gating the cause of the nonconformance and evaluating its significance, informing 
the client when necessary and authorizing amendment to, release of or recall of the 
nonconforming work. Every effort should be made to detect nonconformities before 
the work is released to the client, as release of incorrect results can severely damage 
laboratory-client relationship and could lead to miscarriage of justice. If the non-
conformance could recur without wider action being taken (for example, amending 
the QMS or staff re-training), then preventive actions should be authorized at an 
appropriate level to prevent any recurrence.
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All nonconformances, corrective actions and preventive actions should be recorded. 
Corrective actions should be checked for their effectiveness by authorized staff to 
show that the work now conforms to the requirements of the QMS/client. Preventive 
actions should also be monitored to ensure that the nonconformances are not 
 recurring (for example, through audit).
The recognition of nonconformances and the implementation of corrective and pre-
ventive actions are essential elements in continuously improving the effectiveness 
of the laboratory’s performance.
4.9. Control of records/Chain of custody
Laboratories should have systems in place for the creation, identification, manage-
ment, storage, movement/transmission, retrieval and disposal of all records, in both 
paper and electronic formats. 
All laboratory paper records should be easily readable, uniquely identifiable (for 
example, with the date, author and page number) and made in a permanent medium 
such as ink. Pencil should not be used. No record should be deleted. Alterations 
and correction of mistakes which have been made by hand should not obscure the 
original record and should be signed/initialled and dated. The laboratory should also 
have measures in place to safeguard original electronic records (for example, by 
creating backups of computer files), to identify any alterations to them (for example, 
through the electronic audit trails some manufacturers provide in their software) and 
to ensure their integrity and confidentiality.
All records should be filed systematically to make retrieval easy. At the same time, 
they should be treated as confidential, the data protection and legislation require-
ments for the rights of an individual to privacy, etc., should be observed and access 
should be restricted to authorized personnel. 
Records may be subdivided into quality and technical records.
Quality records include audit reports, proficiency tests, customer feedback, corrective 
and preventive actions, and management reviews. The records should be uniquely 
identifiable (for example, with the date, author, etc.) and held in a safe and secure 
location which is accessible to relevant staff. The laboratory should have a policy 
for how long these records should be kept, (for example, based on legal require-
ments). Records for disposal should be treated as confidential waste and incinerated 
or shredded.
Technical records include all materials relating to cases, including sample sub mission 
forms, chain of custody documents, case notes (including drawings and diagrams), 
photographs, records of telephone conversations, spectra, calibration and 
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other quality control data, instrumental operating parameters and print-outs, reports, 
statements, etc., instrument maintenance records, and staff training, competency and 
authorization records. They should be made at the time the work is done. 
Each entry of every record should be traceable to the analyst/examiner and, where 
appropriate, to a uniquely identified case or exhibit. It should be clear from the case 
record who has performed all stages of the analysis/examination and when each 
stage of the analysis/examination was performed, (for example, the relevant dates). 
All records should contain sufficient information to allow an audit trail to be 
 established showing who did what work and how and when it was done. 
Critical findings (for example, odours and visual observations such as colour tests 
that cannot be independently confirmed from the record at a later time, calculations 
and data transfers which do not form part of a validated electronic process) should 
be checked, preferably by a second authorized person. 
The laboratory should have documented procedures for the overall review of case 
records by authorized persons. The case record should include an indication that 
such checks and reviews have been carried out, when and by whom. This may be 
indicated in a number of ways (for example, by entries against each finding, entry 
on a summary of findings or a statement to this effect in the records). If the checker 
or case reviewer disagrees on any point in the initial record, the reason(s) for the 
disagreement and any action taken as a result should be recorded.
In general, the records required to support conclusions should be such that, in the absence 
of the analyst/examiner, another competent analyst/examiner could evaluate what had 
been performed, interpret the data [12] and, where appropriate, repeat the work. When 
a test result or observation is rejected, the reason(s) should be recorded. This information 
is necessary for another analyst to understand how the case was managed.
Technical records should be kept in a safe and secure place, to prevent damage, 
deterioration, unauthorized access or loss, for a period depending on the needs of 
the client and any relevant regulations in the laboratory’s jurisdiction. The length 
of retention may also depend on the nature of the crime involved, such that records 
for serious offences, such as homicide and drug trafficking, are kept longer than 
those for minor offences, such as simple possession of a controlled drug. This could 
result in case records being retained indefinitely, being destroyed at the end of the 
legal process, or some intermediate arrangement. Records for disposal should be 
treated as confidential waste and incinerated or shredded.
4.10. Internal audit
The laboratory should have a schedule and procedure for periodic audit of all ele-
ments of its activities (for example, each test method) to verify that its operations 
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comply with the requirements of its QMS. The audits should be organized by the 
quality manager at least once per year and carried out and reported by trained, 
qualified personnel who are, whenever resources permit, independent of the activity 
to be audited. When audit findings cast doubt on the effectiveness of the operations 
or on the correctness or validity of the laboratory’s work, the findings should be 
discussed by the auditor, the quality manager and relevant staff, and appropriate 
corrective actions agreed. The laboratory should promptly notify clients in writing 
if the audit shows that the laboratory results were incorrect. 
The area of activity audited, the audit findings and corrective actions should be 
recorded. Future audits of the same activity should record how effective the 
corrective actions have been in order to identify lessons learned and consequently 
improve the laboratory’s performance.
4.11. Management reviews
The quality manager should organize an annual review of the laboratory’s QMS and 
its testing activities to ensure that they remain suitable and effective or to identify 
any changes and improvements required. The review should be carried out by high 
level management of the organization of which the laboratory is a part, the quality 
manager and other relevant staff. The review and any recommended actions should 
be recorded and the actions carried out within an appropriate timescale, agreed 
between the reviewers and the quality manager, taking into account availability of 
resources.
The management review should cover the following areas:
Changes in the volume and type of work; "
Quality control activities, resources and staff training and other relevant  "
factors;
The suitability of policies and procedures; "
Reports from managers and supervisors; "
The outcome of recent internal audits; "
Assessments of external bodies; "
Client feedback; "
Complaints; "
The results of inter-laboratory comparisons or proficiency tests; "
Corrective and preventive actions; "
Recommendations for improvement. "
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5. Technical requirements
5.1. Introduction
Various factors, such as personnel, accommodation and environment, test methods, 
method validation, equipment, reference standards, sampling and the handling of 
test items, contribute towards the accuracy and reliability of results and also deter-
mine to a large extent the uncertainty of the measurement. These factors should all 
be taken into account when developing methods and procedures, in the training of 
personnel, and in the choice and use of equipment.
5.2. Personnel
Staff are the laboratory’s most valuable asset. The laboratory should foster an atmos-
phere wherein employees are encouraged to improve their knowledge and skills, to 
grow as individuals and to fully develop their potential.
The laboratory should only use personnel with whom it has an employment contract, 
including temporary staff. The laboratory management should ensure that the staff 
have the appropriate education, training, experience, knowledge, skills and abilities 
(i.e. competence) to do the work assigned [13], are appropriately supervised and 
work in accordance with laboratory’s QMS. 
The laboratory should have policies and procedures for identifying training needs 
and providing training for staff to help them achieve and maintain competence (for 
example, through structured on-the-job training programmes, participation in scien-
tific meetings, conferences and workshops, technical training courses, instrument 
operation and maintenance courses taught by vendors, in-house technical meetings, 
courses, seminars, and further education). While staff are being trained they should 
be more closely supervised and the effectiveness of their training should be moni-
tored and evaluated. Where test- or technique-specific training is given, acceptance 
criteria should be assigned (for example, observation of the relevant tests or analyses 
by an experienced officer, or their satisfactory performance in the analysis of quality 
control/quality assurance samples and correlation of results with those obtained by 
other trained staff). Where necessary, training programmes should also include 
 training in the presentation of evidence in court.
Guidance for the Implementation of a Quality Management System in Drug Testing Laboratories 15
A record should be maintained for each member of staff of their education, quali-
fications and training, together with a list of tasks they are competent to perform 
and authorized to carry out (for example, to perform particular types of test, to issue 
test reports, to give opinions and interpretations, and to operate particular types of 
equipment). This information should be readily available to staff and should include 
the date on which competence and authorization are confirmed, so all staff have a 
clear understanding of the scope of their assigned tasks and their responsibilities.
Each member of staff should have a current job description which they have agreed 
with their designated line manager. This should include their responsibilities, duties 
and required competencies.
(ISO 17025 does not suggest person specifications (educational qualifications, 
knowledge, skills, competencies, etc.) required for particular jobs. However, 
 recommendations for these can be found in other documents [4, 13].)
5.3.  Accommodation and 
environmental conditions
The types of sample analysed in the laboratory (seized materials or biological speci-
mens, or both) and the number of staff and projected workload will affect the 
requirements for space, storage and security. 
The laboratory premises and environmental conditions should permit the work to 
be carried out to the required quality standards. Particular care should be taken when 
work is carried out at external locations rather than in the main laboratory premises. 
Factors to be considered include space, security, health and safety of staff, tempera-
ture and humidity control, lighting, and air flow and ventilation, in addition to the 
provision of basic laboratory facilities (for example, electricity, gas, water, telephone 
and computer connections, laboratory benches, safety cabinets, refrigerators and 
freezers). 
Laboratory facilities should enable correct performance of the work and where spe-
cific environmental conditions are critical they should be specified, documented and 
monitored (for example, storage temperatures of samples). Environmentally sensitive 
equipment should be in low-access areas and microbalances should be protected 
from vibration and chemical corrosion. Adequate and appropriate space should be 
allocated for each activity/function and employee. Special accommodation should 
be provided for the storage of bulk quantities of dangerous materials, such as com-
pressed gases, solvents and hazardous chemicals, to ensure the health and safety of 
staff. In addition, suitable accommodation is required for the storage of evidential 
materials to prevent loss, deterioration or contamination and so maintain the integrity 
and identity of the evidence, both before and after it has been examined.
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The laboratory areas should be sufficiently clean and tidy to minimize the risk of 
contamination and ensure that the quality of the work carried out is not compro-
mised. There should thus be effective spatial separation of incompatible activities 
(for example, the examination of bulk seized materials and the trace analysis of 
drugs in biological specimens) which should not be carried out using the same 
facilities. Measures should also be taken to prevent cross-contamination (for  example, 
between two different bulk seizures or between reference materials and case  samples). 
These measures might include control of staff movement, flow of samples and 
 sharing of equipment (for example, opened biologically hazardous specimens and 
dirty glassware should not be transported through unprotected areas and glassware 
for the analysis of seized materials (involving high concentrations of drugs should 
not be used for the trace analysis of biological specimens).
Drug testing laboratories and evidence storage areas should be kept secure at all 
times to prevent theft or interference and there should be limited, controlled access. 
There should be controls at both entry and exit points of buildings and between 
different secure areas (for example, by use of keys, or magnetic cards distributed 
to authorized personnel for specific purpose)s. In this way, no unauthorized  personnel 
will be able to handle samples or gain access to restricted areas where drugs, 
 specimens or records are stored. 
The laboratory should hold on record a list of all staff who are authorized to enter 
the secure laboratory areas. This list should be reviewed and updated on a regular 
basis. Unauthorized persons needing to enter secure areas (for example, other 
 laboratory personnel, clients, service engineers, cleaners, administrative personnel 
and visitors) should be escorted at all times by authorized personnel and a record 
of these entries should be maintained.
5.4. Health and safety
The laboratory should have a safety manual containing procedures that address issues 
affecting the health and safety of the staff and which are designed to safeguard 
employees from service-related injury and health problems. These should be based 
on risk assessments of all activities and documented safe systems of work (for 
example, the need to handle hazardous chemicals, such as those used to spray TLC 
plates, in exhaust hoods). 
Details of the following should be contained in the safety manual:
Designated staff with responsibility for aspects of safety (for example,  "
safety officer, biological safety officer, fire safety officer, first aid staff). 
These responsibilities can be held by several people or by a single member 
of staff;
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Emergency procedures and contact information (for example, what to do  "
in the event of fire, chemical spillages, personal injury);
Staff training (for example, fire drills and first aid); "
Accommodation (for example, hand wash facilities, emergency showers,  "
first aid cabinets, eye wash bottles, safety cabinets/exhaust hoods, auto-
claves, fire extinguishers, solvent and chemical stores, disposal facilities for 
waste, chemicals, sharps and radioactive material, safety signs/hazard 
 warnings, notices for fire exits and location of safety equipment, and 
 emergency telephone numbers);
Personal protective equipment (PPE) (for example, laboratory coats, dis- "
posable gloves, goggles/safety glasses, face protectors, ear protectors and 
radiation safety badges);
General laboratory hygiene/safety (for example, cleaning and disinfection  "
of surfaces, autoclaving of biologically contaminated equipment, the wear-
ing of PPE, prohibition of eating, drinking and smoking in the laboratory, 
prohibition of laboratory clothing in designated clean areas and prohibition 
of lone working in laboratories);
Specific biological hazards (for example, the use of microbiological safety  "
cabinets, immunization of staff, safe disposal of clinical waste, sterilization 
of equipment and PPE);
Radioactivity hazards (for example, reference to relevant regulations dealing  "
with the use of radioactive materials).
5.5.  Test methods, method validation [14] 
and procedures
The laboratory should use appropriate methods and procedures for all of its work: 
sampling, handling, transport and storage of evidence, use of equipment, testing, 
evaluation and interpretation of results, and reporting. The methods and procedures 
should be up to date, fully documented and readily available to relevant personnel. 
The documentation of methods should record:
The name/reference number of the method; "
The scope of the method (for example, analytes, matrix, concentration  "
range, known interferences);
The theory and principle of the method; "
A summary of the validation parameters [14] and reference to the location/ "
identity of the file containing the validation data;
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The chemicals, apparatus and equipment required, including technical  "
specifications;
The reference standards/materials required; the environmental conditions  "
required (for example, room temperature) and any stabilization period 
needed (for example, equilibration periods for TLC);
A step by step description of the procedure, including: "
any special precautions which should be observed (for example, health  –
and safety issues);
the requirements for sampling, labelling, packaging, transporting and  –
storing of samples;
the preparation of samples, reference materials, controls and calibrators  –
for analysis;
the requirements for equipment checks and calibration (for example,  –
running a standard sample, tuning and calibration of a mass 
spectrometer);
the analysis process/test procedure and quality control (for example, use  –
of blanks, controls and calibrators);
the recording and processing of results (for example, calculations,  –
 preparation of calibration curves and charts), including the criteria and/
or requirements for acceptance/rejection (for example, if results are 
outside the calibration range or quality controls give unacceptable 
results);
the requirements for the reporting of results; –
the requirements for reporting the uncertainty* of the method. –
(Further information concerning uncertainty is given elsewhere [14, 15].)
If a procedure for the identification or quantification of a drug involves the use of 
more than one method, then the way in which they are linked should be explained 
(for example, with a flow chart or textual description), as should the combination, 
evaluation and reporting of results.
Any departure from these methods and procedures should only be allowed if they 
are justified, authorized, agreed with the client, where appropriate, and 
documented.
 * The word “uncertainty” means “doubt”, and so in the broadest sense “uncertainty of measure-
ment” means doubt about the validity of the result of a measurement as well as doubt as to the exactness 
of the result. Uncertainty of measurement comprises, in general, many components. The laboratory should 
attempt to identify all the components of uncertainty and make a reasonable estimation and should ensure 
that the form of reporting of the result does not give a wrong impression of the uncertainty. 
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Method development and method validation
The methods and procedures used should preferably be based on work published in 
peer-reviewed scientific journals, (for example, Forensic Science International, 
 Journal of Analytical Toxicology, Journal of Chromatography and the UNODC 
ST/NAR publications which are based on published work) and should take account 
of the needs of the client. If published methods are not available, in-house methods 
developed by the laboratory could be authorized, provided they are fit for purpose 
and meet the needs of the client. In these situations, a record should be kept of 
what was undertaken, in sufficient detail to make it possible for another suitably 
qualified individual to understand the method used and the results obtained.
All methods, including non standard/in-house methods, must be “validated” or 
 “verified” to demonstrate that they are fit for purpose and will perform in the labora-
tory’s operational environment. All validations and verifications must be carried out 
according to the laboratory’s approved procedure and be fully documented. 
Validation is the confirmation by examination and the provision of objective evidence 
that the particular requirements for a specific intended use are fulfilled. Validation 
should be as extensive as is necessary. Guidance on what is appropriate under dif-
ferent circumstances and for different methods can be found in many publications 
(for example, UNODC Guidelines on Validation of Analytical Methodology and 
Calibration of Equipment used for Testing of Illicit Drugs in Seized Materials and 
Biological Specimens, and the references therein). Verification is similar to validation 
but is used when a method has been validated elsewhere and shows that it performs 
to the required specification in the hands of the laboratory staff. It is discussed fully 
in the UNODC manual [14]. 
When computers or automated equipment are used for the acquisition, processing, 
recording, reporting, storage or retrieval of test or calibration data, the laboratory 
should ensure that computer software developed by the user is documented in suf-
ficient detail and is suitably validated.
The laboratory should record the personnel involved in the validation work, dates, 
the results obtained, the procedure used, a statement as to whether the method is 
fit for its intended use and the authorization/approval signature.
When a laboratory introduces a method which has been validated elsewhere, it 
should first demonstrate the reliability of the procedure in-house against any per-
formance characteristics of the procedure published in the literature. Records of this 
performance verification should be maintained for future reference.
If a procedure for the identification or quantification of a drug involves the use of 
more than one method, then each method should be validated/verified.
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Composition of a sample run sequence/analytical batch 
A run sequence or analytical batch is a group of samples analysed at the same time. 
It usually contains a mixture of test samples, controls and calibrators. The composi-
tion of an analytical batch depends on the methodology to be used and the purpose 
of the analysis. Three types of methodologies are considered: immunoassays (for 
biological specimens), qualitative analyses and quantitative analyses. As a general 
policy, a minimum of 10 per cent of all samples in a batch should correspond to 
calibrator and control samples. This applies to all types of analysis. [4]
Immunoassays
A batch of samples analysed by immunoassay should contain at least one 
negative control sample (for example, a drug-free urine sample), one or more 
calibrator samples—one of which should contain the analyte at the cut-off 
concentration, and at least one positive control sample. These are usually 
included in a commercial immunoassay kit.
Qualitative analyses
The qualitative identification of a drug or metabolite should be based on direct 
comparison of the analytical data for the submitted specimen with the corre-
sponding data obtained for a reference standard analysed at the same time 
under the same conditions. For this reason, sample batches for qualitative analy-
sis should include reference standards for each of the anticipated drug 
analytes.
Quantitative analyses
A sequence of samples for quantitative analysis should contain blank samples 
plus several calibration standards and controls. Six calibration standards are 
recommended, at concentrations inside the range used in the validation process 
described below [14]. If the analyte concentration in a sample is outside the 
range of the calibrators, the specimen should be diluted and re-analysed. 
As an alternative, additional calibrators can be analysed in order to cover 
the concentration of the analyte in the specimen, but this approach is less 
 commonly used.
Acceptance of analytical results
Specific criteria for what constitutes a positive test should be established and clearly 
stated in the method procedure. These should also include requirements for accept-
able results for quality control samples. Before a sample can be reported positive 
for one or more drugs, two separate portions of the sample must be analysed, each 
portion by at least two different validated test methods. The two methods should 
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be based on different scientific principles, preferably one of which should provide 
information on the chemical structure of the analyte (for example, IR, MS; or tandem 
methods such as GC-MS).
Also, before a sample can be reported positive, the test results should be checked 
by at least two authorized members of staff (usually the analyst plus one senior 
scientist) who are familiar with the analytical methods. The checks should include 
examination of the test results, quality control results, documentation relating to 
sample handling (for example, the chain of custody record and calculations), and 
any transcribed data (for example, data copied to a spreadsheet). 
Use of control charts in quantitative analysis
An analytical method is in statistical control when results consistently fall within 
established control limits. Compliance with statistical control can be monitored 
graphically with control charts (for example, Shewhart and Cusum charts). These 
are useful for routine analytical methods subject to errors of bias or increased vari-
ability. On a control chart, test results for control samples are plotted against time. 
If the analytical method is in statistical control, all of the results will lie within 
predetermined control limits, which are also usually marked on the chart:
The warning limit, which corresponds to ±2 standard deviations of the  "
analytical method from the mean. 
The action limit, which corresponds to ±3 standard deviations of the  "
 analytical method from the mean. 
A typical example would be a graph of the measured concentrations of control 
samples against date. In this case, all results should lie on or close to the true value 
and lie about this value in a normal distribution. However, even if the method is 
under statistical control, approximately five per cent of results may be expected to 
fall outside the warning limits. If an observed value falls outside the action limit, 
immediate measures must be taken to identify the cause and to take remedial 
action.
As well as highlighting individual results that may deviate from the true value, plots 
of this type readily show if the mean is different from the true value (bias) or if 
there is a regular trend causing the results to drift in a given direction.
Competence of the analyst
Laboratories should institute a procedure to identify infrequently performed tests or 
analyses. For these tests or analyses, there are two methods of demonstrating com-
petence of the analyst, either of which would be equally valid. These are:
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Regular analysis of control samples and use of control charts during periods  "
when casework samples are not being analysed; 
Reverification before the test or analysis in question is performed on a  "
casework sample involving at least the use of an appropriate reference 
material, followed by replicate testing or analysis of the real sample.
5.6. Equipment
Laboratories should ensure the reliability and performance of the equipment used. 
Equipment and software required for the work carried out should be fit for its 
intended purpose and should preferably be available within the laboratory. If equip-
ment outside the laboratory is used, it must comply with the QMS standards. An 
inventory of equipment should be maintained along with records of their location, 
date of purchase, service history and maintenance. Major items of equipment (for 
example, instruments such as spectrometers) should have their own logbook for 
recording this information kept nearby. 
Staff should be trained to use the equipment and only authorized to use it when 
they have been found to be competent. Training and authorization should be 
 documented in staff records. 
When equipment is procured, the manufacturer’s specifications should match or 
exceed the laboratory’s requirements. It should be checked on installation to ensure 
that it meets the manufacturer’s specifications (performance verification, usually 
carried out by the supplier’s installation engineer, also known as the “before use 
check” or “equipment validation”). If an instrument is subsequently moved, the 
installation check should be repeated and its performance certified if necessary (for 
example, a balance will usually need to have its calibration checked if it is moved 
to a new location). 
Equipment should also be checked regularly when it is in use, using documented 
procedures to show that the performance continues to be acceptable (for example, 
an instrument might be checked before each set of samples is analysed to ensure 
that it is working properly). This might include checking temperatures, gas pressures, 
tuning, calibration, etc., depending on the instrument involved. Test samples can 
also be analysed for checking purposes. Appropriate corrective action is taken 
when necessary. Up-to-date instructions on the use and maintenance of equipment 
(for example, abbreviated operating instruction sheets prepared in-house as well 
as instruc tion manuals supplied by the manufacturer) should be readily available, 
 preferably adjacent to the instrument, for use by the appropriate laboratory 
personnel.
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Equipment having a significant influence on the accuracy of test results should be 
calibrated according to a schedule, using documented procedures which are available 
to authorized users. Equipment should be labelled to indicate the status of calibra-
tion (for example, the date when last calibrated and the date or expiration criteria 
when recalibration is due) to ensure that it is not confused with uncalibrated equip-
ment. Critical equipment (for example, balances, thermometers, pipettes) should be 
uniquely identified and calibration records, including certificates if available, should 
be kept.
Staff members responsible for equipment should ensure that regular documented 
check samples, calibrators and blanks are analysed and that the performance speci-
fications are being maintained. Records should be kept of all calibration, mainte-
nance and servicing, whether by in-house personnel or an outside agency. These 
should include:
The unique identifier of the item of equipment and data system, if any; "
The manufacturer, model and serial number; "
The location, if appropriate; "
Performance checks; "
Operating instructions prepared in-house; "
The manual supplied by the manufacturer or reference to its location; "
Dates, results and copies of reports and certificates of all calibrations,  "
acceptance criteria relating to performance, and the due date of the next 
calibration;
The maintenance schedule, where appropriate, and maintenance carried out  "
to date;
Any damage, faults, modification or repair to the equipment. "
Identified faults should be brought to the attention of the person responsible for the 
equipment and for taking corrective actions. If the fault is critical (for example, if 
the light source of a spectrometer is unstable or a vacuum pump is not holding a 
sufficient vacuum pressure), the equipment should be withdrawn from service until 
the problem has been rectified and the manner in which the problem is resolved, 
and the time and date should be recorded in the logbook for the equipment.  Similarly, 
equipment that has been operated incorrectly, such that it no longer gives reliable 
results or has been found to be malfunctioning, should be taken out of service. It 
should be isolated to prevent its use or clearly labelled or marked as being out of 
service until it has been repaired and shown by calibration or test to be working 
properly. Analytical results that were obtained during the period of equipment 
 malfunction should be checked and the procedure for control of nonconformities 
should be initiated (see paragraph 4.8). 
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5.7.  Reference standards, materials 
and reagents
Reference standards, materials and reagents should be adequate for the procedure 
used and they should comply with the quality specifications of the method. Lot/
batch numbers of standards and critical reagents should be recorded and they should 
be tested for their reliability. 
Standards and reagents should be labeled with:
Name; "
Concentration, where appropriate; "
Preparation date and/or expiry date; "
Identity of preparer; "
Storage conditions, if relevant; "
Hazard warning, where necessary. "
The laboratory should have a reagent solution preparation register that is kept in a 
suitable location. When a reagent solution is prepared, the person responsible for 
the preparation should record in that register the date, the ingredient weights and 
volumes actually used and his or her signature. This information is needed to trace 
possible sources of error in an analysis. Assigning each batch of reagent with a 
unique identifying number can be helpful in this respect.
Reference standards, working standards, in-house reference standards, reagents and 
other materials should be correctly stored to ensure their stability and integrity. An 
expiry date furnished by a vendor/manufacturer determines the useful lifetime of 
the standard/reagent/material unless it can be verified beyond that date. Where 
 appropriate, “opened” and “use by” dates should also be recorded.
It is important to note that problems with standards and reagents can arise after they 
have been received in the laboratory. As soon as a container is opened there is a 
risk of it becoming contaminated or otherwise changing in composition. Bottles that 
are not tightly resealed expose their contents to air, with the possible loss or pick-up 
of moisture and absorption of carbon dioxide or other contaminating vapours. Also, 
material might be removed or introduced with a contaminated spatula or pipette, 
and the practices of inserting pipettes into the stock bottle of solvent or other reagent 
and pouring unused portions of solutions back into reagent bottles should be 
 vigorously discouraged. Solvents used for rinsing equipment (for example, the 
microlitre syringes used in gas chromatography) should be changed frequently. All 
personnel involved in this work therefore require appropriate training and need to 
be fully informed of the quality requirements in order to understand the extreme 
care needed to preserve the integrity of these materials. 
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Reference standards should be traceable if possible, which means they can be 
directly related to national or international standards. Certified Reference Materials 
(CRMs) can be used if available [4]. A CRM is a reference standard, usually obtained 
commercially, for which the analyte concentration(s) has been certified by analysis, 
accompanied by, or traceable to, a certificate or other documentation that is issued 
by a Certifying Body. However, few CRMs containing controlled substances are 
available, one exception being alcohol standards. 
In the absence of CRMs, commercial reference standards should be used. These 
commercial reference standards are supplied with a description of their chemical 
identity, purity and concentration (for example, a “specification and certificate of 
analysis”). However, it is recommended that the laboratory should independently 
verify their identity and purity (or concentration) before putting them to use (for 
example, by inter-laboratory comparisons or within the laboratory using a previously 
used reference standards).
The reference standards required for each procedure/method used by the laboratory 
should be documented and should be available in the laboratory. They should be 
appropriate for the test being performed (for example, the drug purity must be known 
accurately and for the analysis of drugs in biological specimens they should contain 
the drug at low concentrations). A record should be maintained describing their 
source, the date of acquisition and the quantity held in the laboratory, as this infor-
mation may be required for national drug control authorities. When standards of 
controlled substances need to be imported or exported, import/export certificates 
should be obtained from the relevant national competent authority [16].
The procedure for preparing working standards from the original reference standards 
should be documented and the verification of the final product should be recorded 
and kept on file. 
Reference standards prepared in-house (for example, from seized materials) should 
be verified as far as is technically and economically practicable by comparison with 
CRMs, commercially available standards or reference samples [17] supplied by 
UNODC. 
The responsibility for acquiring and maintaining reference standards should be given 
to a designated person, who should keep a central register of these materials. The 
register should include all official reference substances and reference preparations 
and unofficial reference standards procured from various outside sources, as well as 
all secondary reference standards or working standards prepared at the laboratory. 
Calibrators, either prepared from the reference standards or purchased, are used to 
calibrate the assay. Where possible, calibrators to be used in the analysis of bio-
logical specimens should be prepared in a matrix similar to that of the specimens. 
Initially, a sufficient number of calibrators should be run to determine the 
 characteristics of the calibration curve: a blank and at least five calibration points 
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are recommended. The stability of the calibration curve should be tested under 
laboratory conditions by the addition of both positive and negative controls.
Controls are prepared from the reference standards and are used to determine the 
linearity and stability of a quantitative determination over time. They should be 
purchased or obtained from a pool of previously analysed samples and weighed or 
measured separately from the calibrators. Where possible, controls should be 
 matrix-matched to specimens and calibrators.
5.8. Handling of test items 
Sampling, labelling and packaging
The laboratory should have procedures for the taking of samples of seized materials 
and biological specimens, both at the scene and within the laboratory, and these 
procedures should be available at the locations where the sampling is undertaken. 
The sampling procedure should ensure that the portion taken for analysis is repre-
sentative of the whole.
The sampling plan and/or sampling procedure, the identification of the person taking 
the sample and the environmental conditions, if relevant, should be recorded. 
For sampling seized materials, the sampling plans and procedures published by 
internationally recognized organizations, such as UNODC [4], ENFSI [18] or 
SWGDRUG [5], are recommended. For sampling biological specimens, the sampling 
plans and procedures published by UNODC [4] or the European Guidelines for 
 Workplace Drug Testing [8] are recommended. 
The general principles are:
For cases involving a small number of discrete items (typically 10 or less),  "
all of the items should be sampled. If individual items are large they should 
be either homogenized before samples are taken or multiple samples from 
the whole item should be taken;
For cases involving larger numbers of items, it is impractical to sample  "
them all and a sampling strategy should be adopted that will ensure that 
what is taken is representative of the whole. If the items are not homo-
geneous, they must first be separated into homogeneous groups and an 
appropriate sampling plan then devised for each group.
The sampling plan may have a non-statistical basis (for example, a management or 
judicial directive) or statistical basis (for example, hypergeometric or Bayesian), but 
should be practical and easy to carry out by non-scientists, avoid unnecessary 
 additional work for the laboratory, be easy to explain and be defensible in court. 
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The laboratory should provide guidelines to ensure that the materials to be 
tested are properly sampled, labelled, packaged, preserved and stored before 
submission to the laboratory. The labelling should be sufficient to allow unique 
identification of the samples and sub-samples and their  relationship with their 
original source. It is important that the packaging will prevent unauthorized 
access to and loss or contamination of the  samples during transit. 
Laboratory receipt, handling and processing
The laboratory should have documented arrangements for the acceptance and return 
of seized materials and/or biological specimens. Specific requirements should be 
provided in relation to material or specimens or equipment (for example, needles) 
that might pose a threat to the health or safety of staff. The documentation accom-
panying the submitted material should refer to each individual item and provide 
sufficient information for the laboratory to identify what work is required. There 
must be an acceptable level of agreement between the details on the sample labels 
and those on the accompanying documentation or submission form. 
Each case should be assigned a unique number and the relevant details entered into 
the laboratory case record system. Persons delivering material to the laboratory for 
examination should be given a signed and dated receipt referring to all the material 
submitted. Subsequent submissions related to the same case should be clearly 
 identified as such using the same unique case number.
At the laboratory, an authorized person should receive and carefully check the sam-
ples and documents. One or more identified individuals should also be authorized 
to reject partially or wholly submissions that do not accord with the laboratory’s 
acceptance policies. They should inform the laboratory manager of any such 
 rejections. Any remedial action taken should always be documented.
When establishing an acceptance procedure, a number of defects such as those listed 
below should be considered as potential grounds for rejection if they cannot be 
resolved:
Error or illegibility in name, identification number or any other information  "
on the label attached to the sample;
More than one label on the specimen; "
Missing sample or specimen label; "
Sample or specimen number repeated; "
Inconsistency between the samples received and the samples listed on  "
accompanying documentation;
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Inadequate sealing that could prejudice the integrity of the sample or  "
specimen;
Evidence of tampering; "
No specimen in the specimen container or excessively leaking specimen. "
The laboratory should have an effective documented system for the secure storage 
of samples, both before and after examination; correlating the samples to other 
information provided with them (for example, the request for analysis), identifying 
any sub-samples prepared from the samples, and showing the progress of analysis, 
date of issue of the report of analysis and the date and subsequent means of disposal 
of any remaining sample after analysis. The system should be designed and operated 
to ensure that samples cannot be confused physically or when referred to in records 
or other documents. 
The laboratory should also have documented procedures and appropriate facilities 
to minimize deterioration and avoid loss or damage to the samples during storage, 
handling and analysis. 
If duplicate biological specimens are submitted, one of the two should be used for 
analysis and the other stored, frozen, for further analysis if necessary. 
Where items are retained by the laboratory after analysis, they should be stored for 
a time specified by the jurisdiction or client. 
There should be documented procedures for the disposal of controlled substances 
and specimens which comply with the applicable laws and procedures of the 
 jurisdiction. Records should be kept of each disposal. 
If items are collected from the laboratory for delivery to a subsequent destination 
(for example, to a court for exhibiting), the details of when the items were handed 
over, and to whom, should be recorded in a logbook, which should be signed by 
the recipient.
Specimens such as blood and urine should be considered biologically hazardous and 
should be disposed of in accordance with any applicable laws and procedures.
5.9. Reporting the results
The results of analyses carried out by the laboratory should be reported accurately, 
clearly, unambiguously and objectively, and meet the requirements of the client. The 
report format should be designed to accommodate each type of analysis carried out 
and to minimize the possibility of misunderstanding or misuse.
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If the results of the analysis are likely to be used in courts of law, the  following 
should be considered the absolute minimum for inclusion in the report:
The title of the report; "
The laboratory’s unique identification numbers for the case and each sample  "
or specimen;
The name of the submitting agency or individual; "
The date the specimen was received by the laboratory "
The date the report was prepared; "
Identifiers for the individual pages of the report; "
A description and unambiguous identification of each item analysed; "
The results of analysis; "
The signature and title, or equivalent identification, printed name and  "
employing laboratory of the person(s) accepting responsibility for the 
 content of the report.
Where required and appropriate, an interpretation of the significance of the analysis 
results in the context of the case should also be provided.
Terminology
If a particular substance has been identified in accordance with the laboratory pro-
tocols it should be reported as “the sample/specimen was found to contain” or “the 
analysis was positive for” the presence of the specific substance. The terms “nega-
tive”, “not detected” or “none detected” may be used to indicate the absence of an 
analyte or analytes. “None detected” is preferable as it indicates that particular 
substances were absent within the limitations of the test or tests performed, that is 
below the limit of detection (LOD).
If a substance is detected above the LOD of the assay but below the limit of quan-
tification of the assay (generally considered to be the lowest point on the calibration 
curve) it may be mentioned in the report as a “trace amount”.
If the results of screening/presumptive tests are reported, any result below the des-
ignated cut-off value should be reported as “not detected”. Results above the cut-off 
should be confirmed as present using an appropriate technique and then reported as 
“positive”.
All units of measurement used in the report should comply with the requirements 
of the client.
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Opinions and interpretations
When opinions and interpretations are included, the laboratory should document the 
basis upon which the opinions and interpretations have been made. Opinions and 
interpretations should be clearly identified as such in the report.
Results obtained from subcontractors
When the report contains results of analysis performed by subcontractors, these 
results should be clearly identified.
Amendments to reports 
Material amendments to a report after issue should be made only in the form of a 
further report which indicates that it is a supplementary report and quotes the original 
report reference. When it is necessary to issue a replacement report, this should be 
uniquely identified and should contain a reference to the original that it replaces.
5.10.  Quality control, proficiency testing and 
inter-laboratory comparisons
There should be an appropriate level of quality control for each analysis. Quality 
control check samples should be analysed by the defined procedures, at the required 
frequency. Where control charts are used, a record should be kept of performance 
outside the acceptable criteria.
Results from the random re-analysis of samples should show an acceptable measure 
of agreement with the original analyses.
The laboratory should participate in proficiency testing and inter-laboratory compari-
sons, such as the International Collaborative Exercises (ICE) programme of UNODC 
which is described in a separate publication [10].
Where deficiencies or opportunities for improvement are identified there should be 
a process for taking appropriate action. Improvement and corrective actions should 
be recorded. There should also be an effective system for linking proficiency testing 
performance with day-to-day quality control. 
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Annex. Model for a Quality Manual
Introduction
The Quality Manual is the highest level and most generic document stating the general quality 
policies, procedures and practices of the laboratory. It should outline the structure of the 
documentation used in the QMS. It should also include or make reference to the supporting 
procedures, including technical procedures. To a large extent, the contents of the Quality 
Manual are governed by the requirements of the quality standard to which the laboratory 
adheres, most commonly ISO/IEC 17025:2005, which is the basis of the ”Guidance for the 
Implementation of a Quality Management System in Drug Testing Laboratories”. 
Purpose of the model
This model is intended to give a framework to be used when preparing a Quality Manual. 
Where possible, indications of the contents of the sections of the Quality Manual and some 
suggestions are provided. It is neither possible nor desirable to provide a complete manual 
since the very process of creating one within a laboratory is a training and educational exercise 
important to the staff of the laboratory involved. All laboratories vary in their needs and 
possibilities and these should be reflected in the details of their own, individualized, QMS 
and the Quality Manual which describes how it works.
How to use the model
Sections of the Model should be filled in using the advice given in this Guidance document. 
There is no single “correct” way of completing sections of the Quality Manual. The details provided 
in this document are sufficiently flexible to permit laboratories to impose their own character on 
the final document, as long as each of the requirements listed in ISO 17025 is addressed.
This model therefore shows the headings for the sections of the Quality Manual as an outline 
structure. Details of the QMS can be inserted into the relevant places. Some sections may 
not be relevant and can simply be noted as “not relevant”. Conversely, a laboratory may need 
to introduce additional sections which do not appear in the general outline provided. 
Explanatory notes on information required to be included in the Quality Manual are indicated 
in italics in this Model. 
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QUALITY MANUAL FOR DRUG TESTING LABORATORIES
A model
Organization name:  ___________________________________________________________
Department/Section name, acronym:  _____________________________________________
Address: ____________________________________________________________________
____________________________________________________________________________
Version:  ___________________________________________________________________
 Number of current version
Valid since:  ________________________________________________________________
 Date of issuance of this version
Replacing version:  __________________________________________________________
 Number of previous version
Copy:  _____________________________________________________________________
 Number of copies of current version
Distribution/Placement:  _______________________________________________________
 Hard copy/e.g. Laboratory
Electronic version:  __________________________________________________________
 Laboratory quality folder address
Approved by:  ____________________________  Signature:____________________________
 Name, e.g. Laboratory director
Responsible person:  ______________________  Signature: _________________________
 Name, e.g. Laboratory director
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Laboratory name: Revision:  Date: Page: 3/9 
Quality Manual
Table of contents
Record of updates to quality system
Commitment to the quality system
1. INTRODUCTION: PURPOSE OF THE QUALITY MANUAL
2. INFORMATION ABOUT THE ORGANIZATION
3. QUALITY MANAGEMENT SYSTEM
4. MANAGEMENT REQUIREMENTS
 4.1. Laboratory organization
 4.2. Document control
 4.3. Review of client requests
 4.4. Subcontracting of analytical work
 4.5. Purchasing services and supplies
 4.6. Service to client
 4.7. Complaints
 4.8. Corrective and preventive actions
 4.9. Control of records/chain of custody
 4.10. Internal audit
 4.11. Management reviews
5. TECHNICAL REQUIREMENTS
 5.1. Introduction
 5.2. Personnel
 5.3.  Accommodation and environmental conditions
 5.4. Health and safety
 5.5. Test methods, method validation and procedures
 5.6. Equipment
 5.7. Reference standards, materials and reagents
 5.8. Handling of test items 
 5.9. Reporting the results
 5.10. Quality control, proficiency testing and inter-laboratory comparisons
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Laboratory name: Revision:  Date: Page: 4/9 
Quality Manual
Record of updates to the quality management system
The Quality Manual should be formally reviewed at least once a year. Any change to the 
previous version should be highlighted in the new version.
Version Date Approved by Signature
Insert number of 
latest version
Insert date  
of signature 
of reviewer
Print name of reviewer, 
usually senior 
management
Insert signature 
of reviewer
Continuation sheets are added as required
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Laboratory name: Revision:  Date: Page: 5/9 
Quality Manual
Commitment to the quality management system
I have read the Quality Manual and I am committed to follow the requirements of the Quality 
Management System.
Date Name Signature
Insert date of signature 
of staff member
Print name of  each 
staff member
Insert signature of 
each staff member
Continuation sheets are added as required
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Laboratory name: Revision:  Date: Page: 6/9 
Quality Manual
1. INTRODUCTION: PURPOSE OF THE QUALITY MANUAL
This section should be a brief introduction (one or more paragraphs) to explain what the 
Quality Manual is and why it is needed.
2. INFORMATION ABOUT THE ORGANIZATION
Provide a description of the structure and purpose of the laboratory or department etc, 
indicating its organization and structure, legal position, tasks, values, vision, objectives, strat-
egy, finance and budgeting, etc as relevant.
Also provide contact information:
Address:  
Phone:
Fax:
Email:  
Website:
3. QUALITY MANAGEMENT SYSTEM
3.1. Quality policy statement
Insert a concise statement (usually less than one page) by a top level manager, which should 
be signed and dated. See Guidance document paragraph 3.1. 
3.2 Quality Manual
Insert a statement here about the Quality Manual if not already included at the beginning.
4. MANAGEMENT REQUIREMENTS
4.1. Laboratory organization
This section on organization and management should set down the background and remit of 
the organization. Diagrams are helpful for showing organizational aspects and the roles of 
the key staff, including the relationships between the quality manager and other members of 
the staff. It is recommended that the responsibilities above are shared by different staff members. 
However, depending on the resources some tasks can be delegated to the same person. 
Insert an organization chart showing the management structure of the laboratory, such as:
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For the following sections, 4.2. to 4.11. outline the policies and practices used in your 
 laboratory and provide reference to the relevant QMS documents.
4.2. Document control
Indicate how your document control is organized (e.g. master list/document register as 
 attachment). See Guidance document paragraph 4.2.
4.3. Review of client requests
See Guidance document paragraph 4.3.
4.4. Subcontracting of analytical work
See Guidance document paragraph 4.4.
4.5. Purchasing services and supplies
See Guidance document paragraph 4.5.
4.6. Service to client
See Guidance document paragraph 4.6.
4.7. Complaints
Describe your procedures to handle queries, complaints and system failures as well as corrective 
and preventive actions and evaluation of effectiveness. See Guidance document paragraph 4.7. 
4.8. Corrective and preventive actions
See Guidance document paragraph 4.8.
4.9. Control of records/Chain of custody
Describe how the control of records and chain of custody are performed in your laboratory. 
See Guidance document paragraph 4.9.
Laboratory name: Revision:  Date: Page: 7/9 
Quality Manual
Laboratory 
Manager
Chief 
Analyst
Chief 
Technician
Quality 
Manager
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Laboratory name: Revision:  Date: Page: 8/9 
Quality Manual
4.10. Internal audit
Indicate your system of periodic checks (e.g. annual) or audits to demonstrate that all the 
technical and administrative processes in place to achieve quality are actually being 
 implemented, followed and recorded. See Guidance document paragraph 4.10.
4.11. Management reviews
The content of the management review should be presented. See Guidance document paragraph 4.11.
5. TECHNICAL REQUIREMENTS
For sections 5.2. to 5.10. outline the policies and practices used in your laboratory and 
provide reference to the relevant QMS documents.
5.1. Introduction
See Guidance document paragraph 5.1.
5.2. Personnel
Indicate what personnel files are kept and how they are updated. Provide job titles (names 
of current position holders and responsibilities, qualifications etc., preferably in an annex); 
security clearance level; competence to approve documents; task authorizations; training 
records. Describe general requirements for staff training, personal training and development 
plans, scheduled meetings of staff to discuss the work of the laboratory and other mechanisms 
by which staff should communicate, etc. See Guidance document paragraph 5.2.
5.3. Accommodation and environmental conditions
Describe here e.g. security control, temperature and humidity control, etc. See Guidance 
document paragraph 5.3.
5.4. Health and safety
Describe the procedures for maintaining health and safety, the measures to provide a safe 
working environment for the employees, etc. See Guidance document  paragraph 5.4.
5.5. Test methods, method validation and procedures
See Guidance document paragraph 5.5. See Manual of “Validation of Analytical Methodology 
and Calibration of Equipment used for Testing of Illicit Drugs in Seized Materials and Bio-
logical Specimens”, 2009, UNODC. 
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Laboratory name: Revision:  Date: Page: 9/9 
Quality Manual
5.6. Equipment
Describe the practice in your laboratory regarding the identification and record keeping of 
equipment, etc.  See Guidance document paragraph 5.6.
5.7. Reference standards, materials and reagents
Outline policy and practice concerning the preparation, labelling, storage and use of refer-
ence standards, working standards and reagents, etc. See Guidance document paragraph 
5.7.
5.8. Handling of test items 
Describe where information can be found related to procedures in place such as those used 
for receiving samples, identifying samples against requests for analysis, showing progress of 
analysis, storage of samples, report issue, disposal of samples, etc. See Guidance document 
paragraph 5.8.
5.9. Reporting the results
Describe the format and contents of the reports, the procedure for authorizing their release 
and transmission from the laboratory, etc. See Guidance document paragraph 5.9.
5.10. Quality control, proficiency testing and inter-laboratory comparisons
Describe how the quality of tests is monitored and assessed using reference materials, control 
charts, quality control check samples, proficiency testing, inter-laboratory comparisons, etc. 
See Guidance document paragraph 5.10.
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